The Oxford/AstraZeneca vaccine fails to prevent mild and moderate cases of the South African coronavirus strain, according to research reported in the Financial Times.
AFP
The News You Need, Delivered To You.
Subscribe to the Guardian today and never miss the stories that shape your Business